Mycosis fungoides; circumscribed erythematous lesions in a toddler; large abdominal ecchymotic mass . . . some of the challenges for you in this quiz.
Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.